Tencent-backed AI firm QuantumPharm seeks to raise funds, marking a milestone for Hong Kong’s pre-revenue IPO rules
Tencent-backed artificial intelligence (AI) drug researcher QuantumPharm is raising up to HK$1.13 billion (US$144.5 million) in a Hong Kong initial public offering (IPO) from Tuesday, eyeing the first listing under a new regime for pre-revenue specialist technology firms that was…
Read more